Search

everythinglearnresearchcommunity

for

Search:↓

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Topical antiandrogens might be a good option for male-pattern baldness with fewer side effects, but more research is needed to confirm their safety and effectiveness.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

There is no significant link between male pattern baldness and insulin resistance.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

There's no significant link between blood fat levels and male pattern baldness.

Mice with human gene experienced hair loss when treated with DHT.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss linked to higher heart disease risk in both men and women.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Finasteride effectively treats hair loss in transgender men with few side effects.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Non-obese women with hair loss have higher heart disease risk.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Plum blossom needle acupuncture with qi-invigorating therapy is more effective for Seborrheic Alopecia than Western medicine.

Many men with androgenic alopecia also have dyslipidemia.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Androgenetic alopecia may be linked to metabolic syndrome.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

DHT stops hair regrowth in mice, similar to human hair loss.